Search icon

BIOMEDICAL ACOUSTICS RESEARCH COMPANY - Florida Company Profile

Company claim

Is this your business?

Get access!

Company Details

Entity Name: BIOMEDICAL ACOUSTICS RESEARCH COMPANY
Jurisdiction: FLORIDA
Filing Type: Domestic Profit

BIOMEDICAL ACOUSTICS RESEARCH COMPANY is structured as a Domestic Profit Corporation, which, in Florida signifies a Profit Corporation (also known as a C-Corporation). This business structure is recognized as a separate legal entity from its owners. This offers shareholders the benefit of limited liability protection, safeguarding their personal assets from the corporation's debts and obligations, and facilitates raising capital through the issuance of stock. In Florida, Domestic Profit Corporations are governed by Title XXXVI, Chapter 607, Florida Statutes – Florida Business Corporation Act.

Status: Active

The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness.

Date Filed: 08 Apr 2015 (10 years ago)
Document Number: P15000032322
FEI/EIN Number 36-4250483

Federal Employer Identification (FEI) Number assigned by the IRS.

Address: 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812, US
Mail Address: 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812, US
ZIP code: 32812
County: Orange
Place of Formation: FLORIDA

Key Officers & Management

Name Role Address
SANDLER RICHARD President 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812
SANDLER RICHARD Director 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812
SANDLER RICHARD Agent 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812
MANSY HANSEN A Director 4079 CONWAY PLACE CIRCLE, ORLANDO, FL, 32812

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
EBMJLSXNL1M8
CAGE Code:
57C19
UEI Expiration Date:
2026-02-05

Business Information

Activation Date:
2025-02-07
Initial Registration Date:
2008-09-19

Documents

Name Date
ANNUAL REPORT 2025-02-05
ANNUAL REPORT 2024-01-28
ANNUAL REPORT 2023-01-30
ANNUAL REPORT 2022-01-29
ANNUAL REPORT 2021-01-23
ANNUAL REPORT 2020-01-17
ANNUAL REPORT 2019-01-03
ANNUAL REPORT 2018-01-14
ANNUAL REPORT 2017-01-08
ANNUAL REPORT 2016-01-26

USAspending Awards / Financial Assistance

Date:
2020-12-31
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
A DEVICE FOR MONITORING HEART FAILURE PATIENTS - PROJECT SUMMARY: ABOUT FIVE MILLION PATIENTS CURRENTLY SUFFER FROM HEART FAILURE (HF) IN THE US, RESULTING IN ABOUT ONE MILLION HOSPITALIZATIONS ANNUALLY AND A YEARLY COST OF > 30 BILLION USD. THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP AN INNOVATIVE TECHNOLOGY TO ASSIST HF OUTPATIENT MANAGEMENT. THE PROPOSED DEVICE WILL BE USED BY HEALTH CARE PROVIDERS TO DETECT HF DETERIORATION, WHICH MAY FACILITATE EARLY THERAPEUTIC INTERVENTION, AND POSSIBLY REDUCED HOSPITALIZATION, MORBIDITY, COST AND POTENTIALLY MORTALITY. THE PROJECT IS AN IMPORTANT STEP IN LATER BUILDING A FOLLOW UP DEVICE FOR IN HOME MONITORING. THE TECHNOLOGY RELIES ON DETECTING CHANGES IN LOW-FREQUENCY CHEST WALL VIBRATIONS DUE TO HEART CONTRACTION. THESE SUB-AUDIBLE VIBRATIONS CAN BE DETECTED AND ANALYZED WITH APPROPRIATE SENSORS AND DIGITAL SIGNAL PROCESSING METHODS. THE PROPOSED FIRST-GENERATION NOVEL DEVICE IS NOT INTENDED FOR INITIAL DIAGNOSIS OF HF PATIENTS (I.E., DISTINGUISHING NORMAL FROM ABNORMAL SUBJECTS); RATHER IT IS INTENDED FOR EARLY AMBULATORY DETECTION OF CHANGES IN CHEST WALL VIBRATIONS THAT MAY BE ASSOCIATED WITH CLINICAL CHANGES IN HF INDIVIDUALS. THE PROPOSED DEVICE WOULD BE NON-INVASIVE, SAFE, AND REQUIRE BRIEF MEASUREMENT TIME (1-2 MINUTES) ONCE A WEEK OR AS NEEDED. ALL OBJECTIVES OF PHASE I WERE MET OR EXCEEDED. DURING PHASE II, CERTAIN DEVICE ENHANCEMENTS WILL BE IMPLEMENTED AND A FIRST-GENERATION PROTOTYPE WILL BE BUILT. THE DEVICE WILL BE TESTED IN HF SUBJECTS DURING HOSPITALIZATION AND POST-DISCHARGE. THESE HUMAN STUDIES WILL HELP DELINEATE CHEST VIBRATION CORRELATES OF HF STATUS CHANGES. IF THE PROJECT IS SUCCESSFUL, THE PROPOSED NOVEL TECHNOLOGY WOULD BE USED BY HEALTHCARE PROVIDERS (AND LATER BY HF OUTPATIENTS AT HOME) AS A RAPID ASSESSMENT AND MONITORING TOOL DURING HEALTHCARE PROVIDER VISITS. IT IS EXPECTED THAT THE ENVISIONED DEVICE WOULD BE COMPACT, EASY AND COMFORTABLE TO USE, RAPID, INEXPENSIVE AND SAFE.
Obligated Amount:
1333850.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 01 Jun 2025

Sources: Florida Department of State